Premium
O2‐04–04: Memantine for moderate and severe Alzheimer's disease: Systematic review and meta‐analysis of nine trials
Author(s) -
McShane Rupert,
Sastre Almudena Areosa,
Minakaran Neda
Publication year - 2008
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2008.05.334
Subject(s) - memantine , meta analysis , disease , medicine , psychology , dementia
using paired-samples t-test. Results: Significant improvement in apathy was noted in item-total, frequency, severity, of the NPI-A at 12 weeks. Caregiver distress and IADLs improved significantly. None of the patients dropped out of the study due to adverse effects. Conclusions: Methylphenidate was effective and well tolerated in these patients with DAT. Caregiver distress and functional status also improved with treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom